Communicable disease control and health protection handbook /
"Sales handles: Clear and concise content that combines science with practical guidance. Covers basic principles of communicable disease control and health protection, major syndromes, control of individual infections, main services and activities, organizational arrangements for all EU countri...
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Hoboken, N.J. :
Wiley-Blackwell,
2019.
|
Edición: | 4th edition. |
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Intro; Title Page; Copyright Page; Contents; About the authors; Foreword; Abbreviations; Section 1 Introduction; 1.1 How to use this book; 1.2 Basic concepts in the epidemiology of infectious disease; 1.3 Basic concepts in the prevention of infection; 1.4 Emergency risk communication; 1.5 Health protection on-call; Section 2 Common topics; 2.1 Meningitis and meningism; 2.2 Gastrointestinal infection; 2.3 Community acquired pneumonia; 2.4 Rash in pregnancy; 2.5 Rash and fever in children; 2.6 Illness in returning travellers; 2.7 Jaundice; 2.8 Infection in the immunocompromised
- Section 3 Diseases3.1 Amoebic dysentery; 3.2 Anthrax; 3.3 Bacillus cereus; 3.4 Botulism; 3.5 Brucellosis; 3.6 Campylobacter; 3.7 Chickenpox and shingles (varicella-zoster infections); 3.8 Chikungunya; 3.9 Chlamydia pneumoniae; 3.10 Chlamydia trachomatis; 3.11 Cholera; 3.12 CJD and other human transmissible spongiform encephalopathies; 3.13 Clostridium difficile; 3.14 Clostridium perfringens; 3.15 Coronavirus (including MERS and SARS); 3.16 Cryptosporidiosis; 3.17 Cyclosporiasis; 3.18 Cytomegalovirus; 3.19 Dengue fever; 3.20 Diphtheria
- 3.21 Enterococci, including Glycopeptide-Resistant Enterococci (GRE)3.22 Enterovirus infections (including hand, foot and mouth disease); 3.23 Epstein-Barr Virus; 3.24 Giardiasis; 3.25 Gram-negative bacteraemia (including carbapenem-resistant enterobacteriaceae); 3.26 Gonorrhoea, syphilis and other acute STIs; 3.27 Hantavirus infection; 3.28 Head lice; 3.29 Helicobacter pylori; 3.30 Hepatitis A; 3.31 Hepatitis B; 3.32 Hepatitis C; 3.33 Hepatitis, delta; 3.34 Hepatitis E; 3.35 Herpes simplex; 3.36 Haemophilus influenzae type b (Hib); 3.37 HIV; 3.38 Influenza; 3.39 Japanese B encephalitis
- 3.40 Legionellosis3.41 Leprosy; 3.42 Leptospirosis; 3.43 Listeriosis; 3.44 Lyme disease; 3.45 Malaria; 3.46 Measles; 3.47 Meningococcal infection; 3.48 MRSA (Meticillin-Resistant Staphylococcus aureus); 3.49 Mumps; 3.50 Mycoplasma pneumoniae infection; 3.51 Norovirus; 3.52 Paratyphoid fever; 3.53 Parvovirus B19 (fifth disease); 3.54 Plague; 3.55 Pneumococcal infection; 3.56 Poliomyelitis; 3.57 Psittacosis; 3.58 Q fever; 3.59 Rabies; 3.60 Relapsing fever; 3.61 Respiratory Syncytial Virus (RSV); 3.62 Ringworm; 3.63 Rotavirus; 3.64 Rubella; 3.65 Salmonellosis; 3.66 Scabies; 3.67 Schistosomiasis
- 3.68 Shigellosis3.69 Shiga toxin-producing Escherichia coli (STEC) and other diarrhoeagenic E. coli; 3.70 Smallpox; 3.71 Staphylococcal food poisoning; 3.72 Streptococcal infections; 3.73 Tetanus; 3.74 Threadworms; 3.75 Tick-borne Encephalitis; 3.76 Toxocariasis; 3.77 Toxoplasmosis; 3.78 Tuberculosis (and non-tuberculous mycobacteria); 3.79 Tularaemia; 3.80 Typhoid fever; 3.81 Vibrio parahaemolyticus infection; 3.82 Viral haemorrhagic fevers, including Ebola; 3.83 Warts and verrucae (and molluscum contagiosum); 3.84 West Nile virus; 3.85 Whooping cough; 3.86 Yellow fever; 3.87 Yersiniosis